Kezar Life Sciences, Inc. — Director's Dealing 2021

Dec 10, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2021-12-09

Reporting Person: Wallace Courtney (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-12-09	Stock Option (right to buy)	$13.87	A	52000	Acquired	2031-12-08	Common Stock (52000)	Direct

Footnotes

F1: One thirty-sixth (1/36th) of the shares shall vest on a monthly basis following the vesting commencement date of December 9, 2021, subject to the Reporting Person continuing to provide service through each such date.